Dr. Joseph Jankowski

Principal Faculty

faculty member of Innovation Institute & works in Henry Ford Innovations as leader of its technology management group. He is a nationally-recognized commercialization leader, specializing in early-stage biomedical opportunity assessment and corporate financing and structuring.

structuring. He has contributed to the formation of more than 40 new enterprises ('spinoff companies') and has held leadership positions in multiparty innovation programs that include the NIH CTSA Key Functions Committee and the Philips Global Advanced Imaging Innovation Center.

Jankowski is active in corporate-level governance, having served as a founding or current board member and trustee for a myriad of entrepreneurial enterprises, including Arteriocyte, Bio Enterprise Corporation, JumpStart, Polgenix and Thermalin Diabetes.